Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients

Molecular Psychiatry

Volumn 16, Issue 4, 2011, Pages 419-428

  Kim, H W ^a   Rapoport, S I ^a   Rao, J S ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

COX; excitotoxicity; inflammation; mood stabilizers; PGES; PLA2

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONIC ACID; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P450; CYTOCHROME P450 EPOXYGENASE; CYTOSOLIC PHOSPHOLIPASE A2; MESSENGER RNA; PHOSPHOLIPID; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN SYNTHASE; PROTEIN; SECRETORY PHOSPHOLIPASE A2; THROMBOXANE SYNTHASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; BRAIN; BRAIN CORTEX; CADAVER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ARACHIDONIC ACID; BIOSYNTHETIC PATHWAYS; BIPOLAR DISORDER; BRAIN; CASE-CONTROL STUDIES; CELL MOVEMENT; CYCLOOXYGENASE 2; CYTOSOL; FEMALE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MALE; MIDDLE AGED; PHOSPHOLIPASES A2, CYTOSOLIC; PHOSPHOLIPASES A2, SECRETORY; PHOSPHOPYRUVATE HYDRATASE; POSTMORTEM CHANGES; SCAVENGER RECEPTORS, CLASS E; STATISTICS AS TOPIC; UP-REGULATION;

EID: 79953043445     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2009.137     Document Type: Article

References (86)

1. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord 2003; 73: 123-131. (Pubitemid 36044640)
2. Bostwick JM, Pankratz VS. Affective disorders and suicide risk: a reexamination. Am J Psychiatry 2000; 157: 1925-1932.
3. Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 2008; 13: 197-207.
4. Hashimoto K, Sawa A, Iyo M. Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry 2007; 62: 1310-1316. (Pubitemid 350060893)
5. Lyoo IK, Sung YH, Dager SR, Friedman SD, Lee JY, Kim SJ et al. Regional cerebral cortical thinning in bipolar disorder. Bipolar Disord 2006; 8: 65-74. (Pubitemid 43356022)
6. Rao JS, Harry J, Rapoport SI, Kim H-W. Increased excitotoxicity markers and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 2009; doi:10.1038/mp.2009.47.
7. Moskvina V, Craddock N, Holmans P, Nikolov I, Pahwa JS, Green E et al. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry 2009; 14: 252-260.
8. Ledda MG, Fratta AL, Pintor M, Zuddas A, Cianchetti C. Early-onset psychoses: comparison of clinical features and adult outcome in 3 diagnostic groups. Child Psychiatry Hum Dev 2009; 40: 421-437.
9. Lyketsos CG, Corazzini K, Steele C. Mania in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1995; 7: 350-352.
10. Ankenman R. Treatment of psychotic symptoms in Alzheimer's patients. J Clin Psychiatry 1990; 51: 437-438. (Pubitemid 20359856)
11. Basselin M, Villacreses NE, Lee HJ, Bell JM, Rapoport SI. Chronic lithium administration attenuates up-regulated brain arachidonic acid metabolism in a rat model of neuroinflammation. J Neuro-chem 2007; 102: 761-772. (Pubitemid 47057299)
12. Lee HJ, Rao JS, Chang L, Rapoport SI, Bazinet RP. Chronic N-methyl-D-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanes-thetized rat. J Lipid Res 2008; 49: 162-168.
13. Rao JS, Ertley RN, Rapoport SI, Bazinet RP, Lee HJ. Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2. J Neurochem 2007; 102: 1918-1927. (Pubitemid 47329252)
14. Cao Z, Henzel WJ, Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science 1996; 271: 1128-1131. (Pubitemid 26075229)
15. Huang J, Gao X, Li S, Cao Z. Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc Natl Acad Sci USA 1997; 94: 12829-12832. (Pubitemid 27518436)
16. Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 1997; 7: 837-847. (Pubitemid 28064897)
17. Bauer MK, Lieb K, Schulze-Osthoff K, Berger M, Gebicke-Haerter PJ, Bauer J et al. Expression and regulation of cyclooxygenase-2 in rat microglia. Eur J Biochem 1997; 243: 726-731. (Pubitemid 27073441)
18. Chang YC, Kim HW, Rapoport SI, Rao JS. Chronic NMDA administration increases neuroinflammatory markers in rat frontal cortex: cross-talk between excitotoxicity and neuroinflammation. Neurochem Res 2008; 33: 2318-2323.
19. Oka A, Itoh M, Takashima S. The early induction of cyclo-oxygenase 2 associated with neurofibrillary degeneration in brains of patients with Fukuyama-type congenital muscular dystrophy. Neuropediatrics 1999; 30: 34-37. (Pubitemid 29161093)
20. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001; 294: 1871-1875. (Pubitemid 33101574)
21. Needleman P, Minkes M, Raz A. Thromboxanes: selective biosynthesis and distinct biological properties. Science 1976; 193: 163-165.
22. Seibert K, Masferrer J, Zhang Y, Gregory S, Olson G, Hauser S et al. Mediation of inflammation by cyclooxygenase-2. Agents Actions Suppl 1995; 46: 41-50.
23. Pepicelli O, Fedele E, Bonanno G, Raiteri M, Ajmone-Cat MA, Greco A et al. In vivo activation of N-methyl-D-aspartate receptors in the rat hippocampus increases prostaglandin E(2) extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. J Neurochem 2002; 81: 1028-1034. (Pubitemid 34809285)
24. Samuelsson B, Morgenstern R, Jakobsson PJ. Membrane prosta-glandin E synthase-1: a novel therapeutic target. Pharmacol Rev 2007; 59: 207-224. (Pubitemid 47481434)
25. Kam PC, See AU. Cyclo-oxygenase isoenzymes: physiological and pharmacological role. Anaesthesia 2000; 55: 442-449. (Pubitemid 30301443)
26. Leslie JB, Watkins WD. Eicosanoids in the central nervous system. J Neurosurg 1985; 63: 659-668. (Pubitemid 16198950)
27. O'Banion MK. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol 1999; 13: 45-82. (Pubitemid 29231727)
28. Rao JS, Bazinet RP, Rapoport SI, Lee HJ. Chronic treatment of rats with sodium valproate downregulates frontal cortex NF-kappaB DNA binding activity and COX-2 mRNA. Bipolar Disord 2007; 9: 513-520. (Pubitemid 47202514)
29. Rao JS, Bazinet RP, Rapoport SI, Lee HJ. Chronic administration of carbamazepine down-regulates AP-2 DNA-binding activity and AP-2alpha protein expression in rat frontal cortex. Biol Psychiatry 2007; 61: 154-161. (Pubitemid 46072780)
30. Rao JS, Rapoport SI, Bosetti F. Decrease in the AP-2 DNA-binding activity and in the protein expression of AP-2 alpha and AP-2 beta in frontal cortex of rats treated with lithium for 6 weeks. Neuropsychopharmacology 2005; 30: 2006-2013. (Pubitemid 43093501)
31. Chang MC, Contreras MA, Rosenberger TA, Rintala JJ, Bell JM, Rapoport SI. Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers. J Neurochem 2001; 77: 796-803. (Pubitemid 32466776)
32. Bosetti F, Weerasinghe GR, Rosenberger TA, Rapoport SI. Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain. J Neurochem 2003; 85: 690-696. (Pubitemid 36531932)
33. Bazinet RP, Weis MT, Rapoport SI, Rosenberger TA. Valproic acid selectively inhibits conversion of arachidonic acid to arachido-noyl-CoA by brain microsomal long-chain fatty acyl-CoA synthe-tases: relevance to bipolar disorder. Psychopharmacology (Berl) 2006; 184: 122-129. (Pubitemid 43005765)
34. Basselin M, Chang L, Bell JM, Rapoport SI. Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats. Neuropsy-chopharmacology 2006; 31: 1659-1674. (Pubitemid 44106697)
35. Basselin M, Villacreses NE, Chen M, Bell JM, Rapoport SI. Chronic carbamazepine administration reduces N-methyl-D-aspartate receptor-initiated signaling via arachidonic acid in rat brain. Biol Psychiatry 2007; 62: 934-943. (Pubitemid 47488226)
36. Strokin M, Sergeeva M, Reiser G. Role of Ca2\+-independent phospholipase A2 and n-3 polyunsaturated fatty acid docosahex-aenoic acid in prostanoid production in brain: perspectives for protection in neuroinflammation. Int J Dev Neurosci 2004; 22: 551-557. (Pubitemid 39311444)
37. Nogami M, Takatsu A, Endo N, Ishiyama I. Immunohistochemistry of neuron-specific enolase in neurons of the medulla oblongata from human autopsies. Acta Histochem 1998; 100: 371-382. (Pubitemid 28524615)
38. Rao JS, Rapoport SI, Kim H-W. Decreased GRK3 but not GRK2 expression in frontal cortex from bipolar disorder patients. Inter J Neuropharmacol 2009; 12: 851-860.
39. Rao JS, Kim H-W, Lee H-J, Rapoport SI. Up-regulated arachidonic acid cascade enzymes and their transcription factors in postmortem frontal cortex from bipolar disorder patients. Abstr Soc Neurosci 2007; 37: 707.705.
40. Dwivedi Y, Rizavi HS, Rao JS, Pandey GN. Modifications in the phosphoinositide signaling pathway by adrenal glucocorticoids in rat brain: focus on phosphoinositide-specific phospholipase C and inositol 1,4,5-trisphosphate. J Pharmacol Exp Ther 2000; 295: 244-254.
41. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408. (Pubitemid 34164012)
42. Kim H-W, Lee HJ, Rapoport SI, Rao JS. Hyperglutamatergic state in postmortem frontal cortex of bipolar disorder patients. Soc Neurosci Abstr 2007; 707: 704/Z703.
43. Coyle TR, Kochunov P, Patel RD, Nery FG, Lancaster JL, Mangin JF et al. Cortical sulci and bipolar disorder. Neuroreport 2006; 17: 1739-1742. (Pubitemid 44621575)
44. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 2000; 48: 766-777.
45. Post RM. Sensitization and kindling perspectives for the course of affective illness: toward a new treatment with the anticonvulsant carbamazepine. Pharmacopsychiatry 1990; 23: 3-17. (Pubitemid 20358138)
46. Osuji IJ, Cullum CM. Cognition in bipolar disorder. Psychiatr Clin North Am 2005; 28: 427-441.
47. Kolko M, de Turco EB, Diemer NH, Bazan NG. Secretory phospholipase A2-mediated neuronal cell death involves gluta-mate ionotropic receptors. Neuroreport 2002; 13: 1963-1966. (Pubitemid 35402120)
48. Saitoh M, Nagai K, Yaguchi T, Fujikawa Y, Ikejiri K, Yamamoto S et al. Arachidonic acid peroxides induce apoptotic Neuro-2A cell death in association with intracellular Ca(2\+) rise and mitochondrial damage independently of caspase-3 activation. Brain Res 2003; 991: 187-194. (Pubitemid 37297948)
49. Garrido R, Mattson MP, Hennig B, Toborek M. Nicotine protects against arachidonic-acid-induced caspase activation, cytochrome c release and apoptosis of cultured spinal cord neurons. J Neurochem 2001; 76: 1395-1403. (Pubitemid 32198244)
50. Garrido R, Springer JE, Hennig B, Toborek M. Apoptosis of spinal cord neurons by preventing depletion nicotine attenuates arachidonic acid-induced of neurotrophic factors. J Neurotrauma 2003; 20: 1201-1213. (Pubitemid 37467283)
51. Toborek M, Malecki A, Garrido R, Mattson MP, Hennig B, Young B. Arachidonic acid-induced oxidative injury to cultured spinal cord neurons. J Neurochem 1999; 73: 684-692. (Pubitemid 29339842)
52. Mueller HT, Meador-Woodruff JH. NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder. Schizophr Res 2004; 71: 361-370. (Pubitemid 39330514)
53. Mundo E, Tharmalingham S, Neves-Pereira M, Dalton EJ, Macciardi F, Parikh SV et al. Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder. Mol Psychiatry 2003; 8: 241-245. (Pubitemid 36315234)
54. Weichel O, Hilgert M, Chatterjee SS, Lehr M, Klein J. Bilobalide, a constituent of Ginkgo biloba, inhibits NMDA-induced phos-pholipase A2 activation and phospholipid breakdown in rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol 1999; 360: 609-615. (Pubitemid 30012459)
55. Zhou HR, Islam Z, Pestka JJ. Kinetics of lipopolysaccharide-induced transcription factor activation/inactivation and relation to proinflammatory gene expression in the murine spleen. Toxicol Appl Pharmacol 2003; 187: 147-161. (Pubitemid 36349346)
56. Baum L, Lam LC, Kwok T, Lee J, Chiu HF, Mok VC et al. Apolipoprotein E epsilon4 allele is associated with vascular dementia. Dement Geriatr Cogn Disord 2006; 22: 301-305. (Pubitemid 44651443)
57. Hauss-Wegrzyniak B, Dobrzanski P, Stoehr JD, Wenk GL. Chronic neuroinflammation in rats reproduces components of the neuro-biology of Alzheimer's disease. Brain Res 1998; 780: 294-303. (Pubitemid 28082916)
58. Richardson RL, Kim EM, Gardiner T, O'Hare E. Chronic intracerebroventricular infusion of lipopolysaccharide: effects of ibuprofen treatment and behavioural and histopathological correlates. Behav Pharmacol 2005; 16: 531-541. (Pubitemid 41416072)
59. Sun GY, Xu J, Jensen MD, Simonyi A. Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res 2004; 45: 205-213. (Pubitemid 38228817)
60. Luschen S, Adam D, Ussat S, Kreder D, Schneider-Brachert W, Kronke M et al. Activation of ERK1/2 and cPLA(2) by the p55 TNF receptor occurs independently of FAN. Biochem Biophys Res Commun 2000; 274: 506-512. (Pubitemid 30614348)
61. Dinarello CA. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 2002; 20(5 Suppl 27): S1-S13. (Pubitemid 35174747)
62. Takemiya T, Matsumura K, Yamagata K. Roles of prostaglandin synthesis in excitotoxic brain diseases. Neurochem Int 2007; 51: 112-120. (Pubitemid 47176705)
63. Hibbeln JR, Palmer JW, Davis JM. Are disturbances in lipid-protein interactions by phospholipase-A2 a predisposing factor in affective illness? Biol Psychiatry 1989; 25: 945-961. (Pubitemid 19122770)
64. Lieb J, Karmali R, Horrobin D. Elevated levels of prostaglandin E2 and thromboxane B2 in depression. Prostaglandins Leukot Med 1983; 10: 361-367. (Pubitemid 13162267)
65. Sublette ME, Russ MJ, Smith GS. Evidence for a role of the arachidonic acid cascade in affective disorders: a review. Bipolar Disord 2004; 6: 95-105. (Pubitemid 38443562)
66. Nishino S, Ueno R, Ohishi K, Sakai T, Hayaishi O. Salivary prostaglandin concentrations: possible state indicators for major depression. Am J Psychiatry 1989; 146: 365-368. (Pubitemid 19078202)
67. Linnoila M, Whorton AR, Rubinow DR, Cowdry RW, Ninan PT, Waters RN. CSF prostaglandin levels in depressed and schizophrenic patients. Arch Gen Psychiatry 1983; 40: 405-406. (Pubitemid 13118574)
68. DeMar Jr JC, Ma K, Bell JM, Igarashi M, Greenstein D, Rapoport SI. One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J Lipid Res 2006; 47: 172-180. (Pubitemid 43107460)
69. Maida ME, Hurley SD, Daeschner JA, Moore AH, O'Banion MK. Cytosolic prostaglandin E2 synthase (cPGES) expression is decreased in discrete cortical regions in psychiatric disease. Brain Res 2006; 1103: 164-172. (Pubitemid 44080118)
70. Thommesen L, Sjursen W, Gasvik K, Hanssen W, Brekke OL, Skattebol L et al. Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1. J Immunol 1998; 161: 3421-3430.
71. Strokin M, Chechneva O, Reymann KG, Reiser G. Neuroprotection of rat hippocampal slices exposed to oxygen-glucose deprivation by enrichment with docosahexaenoic acid and by inhibition of hydrolysis of docosahexaenoic acid-containing phospholipids by calcium independent phospholipase A2. Neuroscience 2006; 140: 547-553.
72. Noponen M, Sanfilipo M, Samanich K, Ryer H, Ko G, Angrist B et al. Elevated PLA2 activity in schizophrenics and other psychiatric patients. Biol Psychiatry 1993; 34: 641-649.
73. Ross BM, Turenne S, Moszczynska A, Warsh JJ, Kish SJ. Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia. Brain Res 1999; 821: 407-413. (Pubitemid 29222805)
74. Greenamyre JT, Young AB. Excitatory amino acids and Alzheimer's disease. Neurobiol Aging 1989; 10: 593-602. (Pubitemid 19245482)
75. McGeer EG, McGeer PL. Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 741-749. (Pubitemid 36966754)
76. Stephenson DT, Lemere CA, Selkoe DJ, Clemens JA. Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol Dis 1996; 3: 51-63. (Pubitemid 26145405)
77. Pasinetti GM, Aisen PS. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 1998; 87: 319-324. (Pubitemid 28370892)
78. Sanchez-Mejia RO, Newman JW, Toh S, Yu GQ, Zhou Y, Halabisky B et al. Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease. Nat Neurosci 2008; 11: 1311-1318.
79. Smith AW, Dougall AL, Posluszny DM, Somers TJ, Rubinstein WS, Baum A. Psychological distress and quality of life associated with genetic testing for breast cancer risk. Psychooncology 2008; 17: 767-773.
80. Dawson E, Gill M, Curtis D, Castle D, Hunt N, Murray R et al. Genetic association between alleles of pancreatic phospholipase A2 gene and bipolar affective disorder. Psychiatr Genet 1995; 5: 177-180. (Pubitemid 26018318)
81. Jacobsen N, Daniels J, Moorhead S, Harrison D, Feldman E, McGuffin P et al. Association study of bipolar disorder at the phospholipase A2 gene (PLA2A) in the Darier's disease (DAR) region of chromosome 12q23-q24.1. Psychiatr Genet 1996; 6: 195-199. (Pubitemid 27192830)
82. Konopaske GT, Dorph-Petersen KA, Sweet RA, Pierri JN, Zhang W, Sampson AR et al. Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol Psychiatry 2008; 63: 759-765. (Pubitemid 351400762)
83. Gomez-Sintes R, Hernandez F, Bortolozzi A, Artigas F, Avila J, Zaratin P et al. Neuronal apoptosis and reversible motor deficit in dominant-negative GSK-3 conditional transgenic mice. EMBO J 2007; 26: 2743-2754. (Pubitemid 46884288)
84. Benes FM. Searching for unique endophenotypes for schizophrenia and bipolar disorder within neural circuits and their molecular regulatory mechanisms. Schizophr Bull 2007; 33: 932-936. (Pubitemid 47216664)
85. Giovacchini G, Lerner A, Toczek MT, Fraser C, Ma K, DeMar JC et al. Brain incorporation of [11C]arachidonic acid, blood volume, and blood flow in healthy aging: a study with partial-volume correction. J Nucl Med 2004; 45: 1471-1479. (Pubitemid 47618500)
86. Esposito G, Giovacchini G, Liow JS, Bhattacharjee AK, Greenstein D, Schapiro M et al. Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET. J Nucl Med 2008; 49: 1414-1421.